The “Program’s” Outside Contractor: Eastern Research Group

FDA has hired an outside firm, Eastern Research Group, to help assess the performance of the new review “Program” for novel drugs and biologics under PDUFA V. That assessment – which will be discussed at two public meetings – will help determine the future of FDA’s new review process after 2017.